Mercury Laboratories Q1 Results
- BSE: 538964
- NSE: -
- ISIN: INE947G01011
- Sector: Biotechnology & Drugs
BSE
760.00
0.00 (0.00%)
0.00 (0.00%)Volume289.00
Updated: Thu 15 Oct, 2026 | 15:21:15
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹15.96 Cr.(-11.98%)
- Operating Profit₹0.46 Cr.(-69.39%)
- Profit After Tax₹0.30 Cr.(-69.22%)
- Operating Margin2.90%(-65.22%)
Note: Comparison is on YoY basis
Quarterly - Mercury Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 15.50 | 19.25 | -19.46% | 15.77 | -6.76% |
| Depreciation/ Amortization | 0.73 | 0.84 | -13.61% | 0.70 | -13.56% |
| Operating Income | 0.46 | 1.20 | -61.32% | 0.91 | -69.39% |
| Net Income | 0.30 | 1.23 | -75.70% | 0.34 | -69.22% |
| Other Operating Expenses Total | 4.44 | 5.98 | -25.76% | 4.73 | 3.60% |
| Net Income Before Taxes | 0.39 | 1.74 | -77.44% | 0.92 | -74.67% |
| Total Revenue | 15.96 | 20.44 | -21.91% | 16.68 | -11.98% |
| Selling/ General/ Admin Expenses Total | 4.24 | 4.57 | -7.38% | 3.84 | -0.15% |
| Diluted Normalized EPS | 2.48 | 10.21 | -75.71% | 2.85 | -69.23% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.